Serum Phosphorus and Cardiovascular Mortality in Type 2 Diabetes

American Journal of Medicine

Volumn 122, Issue 4, 2009, Pages 380-386

  Chonchol, Michel ^a   Dale, Rita ^b   Schrier, Robert W ^a   Estacio, Raymond ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b Colorado Prevention Center ^*  (United States)

^c Denver Health ^*  (United States)

Author keywords

Calcium; Calcium phosphorus product; Cardiovascular disease; Cardiovascular mortality; Phosphorus; Type 2 diabetes

Indexed keywords

CALCIUM; PHOSPHORUS;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RELIABILITY; STATISTICAL SIGNIFICANCE;

ANTIHYPERTENSIVE AGENTS; CALCIUM; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; ENALAPRIL; FEMALE; HUMANS; MALE; MIDDLE AGED; NISOLDIPINE; PHOSPHORUS; PROPORTIONAL HAZARDS MODELS;

EID: 63049135405     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.09.039     Document Type: Article

References (26)

1. Levi M., and Popovtzer M. Disorders of phosphate balance. In: Schrier R.W., Berl T., and Bonventre J.V. (Eds). Atlas of Diseases of the Kidney (2001), Current Medicine, Philadelphia, PA 7.1-7.14
2. Hruska K.A., and Slatopolsky E. Disorders of phosphorus, calcium, and magnesium metabolism. In: Schrier R.W., and Gottschalk C.W. (Eds). Diseases of the Kidney (1997), Little, Brown and Company, New York, NY 2477-2526
3. Bellasi A., Kooienga L., and Block G.A. Phosphate binders: new products and challenges. Hemodial Int. 10 (2006) 225-234
4. Block G.A. Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis). Curr Opin Nephrol Hypertens 10 (2001) 741-747
5. Tonelli M., Sacks F., Pfeffer M., et al. Cholesterol and Recurrent Events Trial Investigators. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 1120 (2005) 2627-2633
6. Dhingra R., Sullivan L.M., Fox C.S., et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167 (2007) 879-885
7. Kestenbaum B., Sampson J.N., Rudser K.D., et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16 (2005) 520-528
8. Block G.A., Hulbert-Shearon T.E., Levin N.W., and Port F.K. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31 (1998) 607-617
9. Block G.A., Klassen P.S., Lazarus J.M., et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15 (2004) 2208-2218
10. Slinin Y., Foley R.N., and Collins A.J. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16 (2005) 1788-1793
11. Savage S., Johnson Nagel N., Estacio R.O., et al. The ABCD (Appropriate Blood Pressure Control in Diabetes) trial: rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes. Control Clin Trials 17 (1996) 242-257
12. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am J Kidney Dis. 39 Suppl 1 (2002) S1-S266
13. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30 (1987) 123-131
14. Estacio R.O., Jeffers B.W., Hiatt W.R., et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 338 (1998) 645-652
15. Gregg E.W., Cheng Y.J., Cadwell B.L., et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 293 (2005) 1868-1874
16. Curb J.D., Pressel S.L., Cutler J.A., et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 276 (1996) 1886-1892
17. Pyorala K., Pedersen T.R., Kjekshus J., et al. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20 (1997) 614-620
18. Goldberg R.B., Mellies M.J., Sacks F.M., et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the Cholesterol And Recurrent Events (CARE) trial. Circulation 98 (1998) 2513-2519
19. Franklin K., Goldberg R.J., Spencer F., et al. Implications of diabetes in patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med 164 (2004) 1457-1463
20. Malmberg K., Yusuf S., Gerstein H.C., et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 102 (2000) 1014-1019
21. Mak K.H., Moliterno D.J., Granger C.B., et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction: GUSTO-I Investigators: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 30 (1997) 171-179
22. Doherty T.M., Fitzpatrick L.A., Inoue D., et al. Molecular, endocrine and genetic mechanisms of arterial calcification. Endocr Rev 25 (2004) 629-672
23. Young M.J., Adams J.E., Anderson G.F., et al. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 36 (1993) 615-621
24. Lehto S., Niskanen L., Suhonen M., et al. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 16 (1996) 978-983
25. Block G.A., Raggi P., Bellasi A., et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71 (2007) 438-441
26. Hallan S., Astor B., Romundstad S., et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: the HUNT II Study. Arch Intern Med 167 (2007) 2490-2496